Product Images Potassium Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Potassium Acetate NDC 65219-510 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Fresenius Kabi Logo - pot0x 0002 01

Fresenius Kabi Logo - pot0x 0002 01

Package Label - Principal Display Panel – Potassium Acetate Injection, USP 20 mL Vial Label - pot0x 0002 02

Package Label - Principal Display Panel – Potassium Acetate Injection, USP 20 mL Vial Label - pot0x 0002 02

This text appears to be a description of a medication contained in a vial with NDC 85219-510-02. The solution inside contains 196 mg of potassium acetate per milliliter with a pH level of 6.2. It may also contain acetic acid for pH adjustment. The medication is sterile, nonpyrogenic, and must be diluted before intravenous use. It is advised to check for clarity and integrity of the seal before use. The medication does not contain aluminum above a specific concentration. It is manufactured by Fresenius Kabi and is a single-dose injection. For detailed instructions and usage, it is recommended to refer to the package insert or consult healthcare professionals.*

Package Label - Principal Display Panel – Potassium Acetate Injection, USP 20 mL Tray Label - pot0x 0002 03

Package Label - Principal Display Panel – Potassium Acetate Injection, USP 20 mL Tray Label - pot0x 0002 03

This text is a product label for a medication named Potassium Acetate Injection, USP. It contains 40 mEq of potassium acetate per 20 mL vial and is meant for intravenous use after being diluted. Each milliliter contains 196 mg of potassium acetate and may also contain acetic acid for pH adjustment. The solution has a calculated osmolality of 4mOsmol/mL and a pH range of 5.5 to 8.0. The usual dose and administration instructions can be found in the insert. It is sterile, nonpyrogenic, and should be added aseptically to a suitable intravenous solution. The product should be stored at room temperature and discarded if the seal is damaged or if it's not clear. This information is provided by Fresenius Kabi, a pharmaceutical company based in Lake Zurich, IL.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.